Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian longitudinal recovery trial (NaltRec study)
Sign Up to like & getrecommendations! Published in 2021 at "Contemporary Clinical Trials Communications"
DOI: 10.1016/j.conctc.2021.100728
Abstract: Opioid-dependence is a comprehensive, relapsing disorder with negative individual, - family, - and societal consequences. Recovery is difficult to achieve. Research has shown reduced substance use and improved health- and psychosocial factors with extended-release naltrexone… read more here.
Keywords: recovery; extended release; release naltrexone; treatment ... See more keywords
Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of substance abuse treatment"
DOI: 10.1016/j.jsat.2016.12.006
Abstract: BACKGROUND AND AIM Extended-release naltrexone (XR-NTX) blocks the effects of opioids for 4weeks, yet many patients continue to use them. To learn more about why this occurs, we collected self-reports on subjective effects and drug… read more here.
Keywords: release naltrexone; heroin; heroin opiates; extended release ... See more keywords
Court personnel attitudes towards medication-assisted treatment: A state-wide survey.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of substance abuse treatment"
DOI: 10.1016/j.jsat.2019.06.011
Abstract: BACKGROUND Despite its efficacy, medication-assisted treatment (MAT) is rarely available in the criminal justice system in the United States, including in problem-solving courts or diversionary settings. Previous studies have demonstrated criminal justice administrators' hostility towards… read more here.
Keywords: justice; court; attitudes towards; release naltrexone ... See more keywords
Extended-release naltrexone: good but not a panacea
Sign Up to like & getrecommendations! Published in 2018 at "The Lancet"
DOI: 10.1016/s0140-6736(17)32872-6
Abstract: Unlike other addictions, opioid-use disorder has several highly effective medication treatments available, in particular methadone, buprenorphine, and naltrexone. Methadone is the least accessible or acceptable of these in many settings, so providers and patients are… read more here.
Keywords: extended release; release naltrexone; treatment; study ... See more keywords